Related Experiment Videos
Teicoplanin in infections caused by methicillin-resistant staphylococci
Y J Drabu1, B Walsh, P H Blakemore
1Department of Microbiology, North Middlesex Hospital, London, UK.
The Journal of Antimicrobial Chemotherapy
|January 1, 1988
Abstract:
Serious infections by methicillin-resistant staphylococci, 26 caused by Staphylococcus aureus and two by coagulase-negative staphylococci, were treated with teicoplanin 200-800 mg daily, in eight cases supplemented with another antibiotic. The overall rate of clinical cure or improvement was 75%, and that of bacterial eradication 67%.